Gestational Diabetes Global Market Report 2025

Description

Gestational diabetes is a type of diabetes that arises during pregnancy when the body fails to produce enough insulin to adequately regulate blood sugar levels. This condition usually emerges in the second or third trimester and can occur in women without a prior history of diabetes. Gestational diabetes poses risks to both the mother and the baby, including high birth weight, premature delivery, and an increased likelihood of developing type 2 diabetes later in life for both. Management typically involves adjustments to diet, regular exercise, blood sugar monitoring, and, if necessary, insulin therapy to support a healthy pregnancy and childbirth.

Gestational diabetes is categorized into several types, including Type A1, Type A2, and other forms. Type A1 refers to gestational diabetes mellitus (GDM) that develops during pregnancy due to insufficient insulin production to meet the increased demands of this period. Treatment strategies often include blood sugar monitoring, medication, and lifestyle interventions, which may be delivered orally, intravenously, or through other methods. These interventions are commonly implemented in hospitals, clinics, home care settings, and diagnostic centers.

The gestational diabetes market research report is one of a series of new reports from The Business Research Company that provides gestational diabetes market statistics, including gestational diabetes industry global market size, regional shares, competitors with gestational diabetes market share, detailed gestational diabetes market segments, market trends, and opportunities, and any further data you may need to thrive in the gestational diabetes industry. This gestational diabetes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gestational diabetes market size has grown strongly in recent years. It will grow from $8.37 billion in 2024 to $9.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historical period can be attributed to various factors, such as the increasing prevalence of diabetes, advancements in blood glucose measurement accuracy, a rise in the number of insurance providers, and a growing population of individuals with diabetes. Furthermore, the expanding diabetic population has played a significant role in driving this growth.

The gestational diabetes market size is expected to see strong growth in the next few years. It will grow to $12.90 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth projected for the forecast period is driven by various factors, including the increasing prevalence of obesity, greater adoption of cloud-based project solutions, and the rising use of related devices and applications. Additionally, the surge in diabetes cases due to unhealthy lifestyle choices, heightened public health awareness, and escalating diabetes rates are significant contributors. Key trends anticipated during this period include the emergence of digital diabetes management apps, closed-loop control systems, advancements in diabetes management technologies, enzymatic innovations, and other cutting-edge medical advancements.

The growing prevalence of obesity is expected to drive the expansion of the gestational diabetes market in the future. Obesity refers to individuals with a body mass index (BMI) of 30 or higher, indicating excessive body fat that can lead to significant health risks. The rise in obesity is influenced by factors such as sedentary lifestyles, the increased intake of high-calorie processed foods, genetic predispositions, and limited access to healthy food and exercise options. Gestational diabetes treatment is particularly important for the obese population, as their increased risk of insulin resistance and excessive weight gain during pregnancy can cause complications for both the mother and baby if left untreated. For example, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental agency, reported that approximately 1 in 8 people worldwide were living with obesity in 2022. This includes 2.5 billion adults aged 18 and older classified as overweight, of which 890 million were living with obesity. Among adults, 43% were overweight, and 16% were obese. Additionally, 37 million children under 5 years old were overweight, and more than 390 million children and adolescents aged 5 to 19 years were overweight, including 160 million living with obesity. As a result, the increasing obese population is driving the growth of the gestational diabetes market.

Leading companies in the gestational diabetes market are focusing on the development of advanced products, such as diagnostic kits, to offer quick, accurate, and convenient methods for early detection of the condition. A diagnostic kit for gestational diabetes is a medical tool used to measure blood glucose levels and detect abnormal glucose tolerance in pregnant women, helping in the early identification and management of the condition. For example, in August 2024, DirectSens GmbH, a biotechnology company based in Austria, introduced the XpressGT RUO kit. This diagnostic kit is designed to detect gestational diabetes, endometriosis, insulin resistance, and liver disease. It measures 2-hydroxybutyrate (2-HB) levels in venous blood, a substance naturally produced by the liver during its normal functions. Elevated 2-HB levels are linked to increased reductive stress, which is associated with various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any clinical analyzer and provides results in just 8 minutes, offering a fast and efficient diagnostic solution.

In April 2024, Digostics, a diabetes home-testing provider based in the UK, partnered with AgaMatrix Europe to advance gestational diabetes screening. This collaboration grants AgaMatrix exclusive rights to distribute Digostics' home oral glucose tolerance testing (OGTT) service, GTT@home, to the UK National Health Service (NHS). By utilizing its strong connections and customer base within NHS maternity services, along with its extensive expertise in gestational diabetes monitoring, AgaMatrix aims to accelerate the introduction of GTT@home in the UK market. AgaMatrix Europe is a UK-based company specializing in the production of blood glucose monitoring solutions.

Major players in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc.

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gestational diabetes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gestational diabetes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gestational diabetes market consists of revenues earned by entities by providing services such as nutritional counseling, medication management, telemedicine services, lifestyle and exercise guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The gestational diabetes market also includes sales of metformin, glyburide, and insulin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gestational Diabetes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gestational diabetes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gestational diabetes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gestational diabetes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Types: Type A1; Type A2; Other Types
2) By Treatment: Monitoring; Drug Treatment; Non-pharmacological treatment
3) By Administration: Oral; Intravenous; Other Administrations
4) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Centers
Subsegments:
1) By Type A1: Diet-Controlled Gestational Diabetes; Exercise-Controlled Gestational Diabetes
2) By Type A2: Insulin-Controlled Gestational Diabetes; Oral Medication-Controlled Gestational Diabetes
3) By Other Types: Pre-Gestational Diabetes; Gestational Diabetes With Complications
Companies Mentioned: Sanofi S.A.; AstraZeneca plc; Abbott Laboratories; Eli Lilly and Company; Novo Nordisk A/S
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33748

1. Executive Summary

2. Gestational Diabetes Market Characteristics

3. Gestational Diabetes Market Trends And Strategies

4. Gestational Diabetes Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Gestational Diabetes Growth Analysis And Strategic Analysis Framework

5.1. Global Gestational Diabetes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gestational Diabetes Market Growth Rate Analysis
5.4. Global Gestational Diabetes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gestational Diabetes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gestational Diabetes Total Addressable Market (TAM)

6. Gestational Diabetes Market Segmentation

6.1. Global Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type A1
Type A2
Other Types
6.2. Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monitoring
Drug Treatment
Non-pharmacological treatment
6.3. Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Other Administrations
6.4. Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care Settings
Diagnostic Centers
6.5. Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diet-Controlled Gestational Diabetes
Exercise-Controlled Gestational Diabetes
6.6. Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insulin-Controlled Gestational Diabetes
Oral Medication-Controlled Gestational Diabetes
6.7. Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pre-Gestational Diabetes
Gestational Diabetes With Complications

7. Gestational Diabetes Market Regional And Country Analysis

7.1. Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gestational Diabetes Market

8.1. Asia-Pacific Gestational Diabetes Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gestational Diabetes Market

9.1. China Gestational Diabetes Market Overview
9.2. China Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gestational Diabetes Market

10.1. India Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gestational Diabetes Market

11.1. Japan Gestational Diabetes Market Overview
11.2. Japan Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gestational Diabetes Market

12.1. Australia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gestational Diabetes Market

13.1. Indonesia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gestational Diabetes Market

14.1. South Korea Gestational Diabetes Market Overview
14.2. South Korea Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gestational Diabetes Market

15.1. Western Europe Gestational Diabetes Market Overview
15.2. Western Europe Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gestational Diabetes Market

16.1. UK Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gestational Diabetes Market

17.1. Germany Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gestational Diabetes Market

18.1. France Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gestational Diabetes Market

19.1. Italy Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gestational Diabetes Market

20.1. Spain Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gestational Diabetes Market

21.1. Eastern Europe Gestational Diabetes Market Overview
21.2. Eastern Europe Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gestational Diabetes Market

22.1. Russia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gestational Diabetes Market

23.1. North America Gestational Diabetes Market Overview
23.2. North America Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gestational Diabetes Market

24.1. USA Gestational Diabetes Market Overview
24.2. USA Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gestational Diabetes Market

25.1. Canada Gestational Diabetes Market Overview
25.2. Canada Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gestational Diabetes Market

26.1. South America Gestational Diabetes Market Overview
26.2. South America Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gestational Diabetes Market

27.1. Brazil Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gestational Diabetes Market

28.1. Middle East Gestational Diabetes Market Overview
28.2. Middle East Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gestational Diabetes Market

29.1. Africa Gestational Diabetes Market Overview
29.2. Africa Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gestational Diabetes Market Competitive Landscape And Company Profiles

30.1. Gestational Diabetes Market Competitive Landscape
30.2. Gestational Diabetes Market Company Profiles
- 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Gestational Diabetes Market Other Major And Innovative Companies

31.1. Becton, Dickinson and Company
31.2. Boehringer Ingelheim GmbH
31.3. Dexcom Inc
31.4. Biocon Limited
31.5. LifeScan Inc
31.6. Ascensia Diabetes Care Holdings AG
31.7. Trividia Health Inc.
31.8. Nipro Diagnostics, Inc.
31.9. Sernova Corp.
31.10. ZyVersa Therapeutics, Inc.
31.11. Peptron Inc.
31.12. Roche Diabetes Care
31.13. DiabetOmics Inc
31.14. Merck & Co. Inc.
31.15. Medtronic plc

32. Global Gestational Diabetes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gestational Diabetes Market

34. Recent Developments In The Gestational Diabetes Market

35. Gestational Diabetes Market High Potential Countries, Segments and Strategies

35.1 Gestational Diabetes Market In 2029 - Countries Offering Most New Opportunities
35.2 Gestational Diabetes Market In 2029 - Segments Offering Most New Opportunities
35.3 Gestational Diabetes Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer